Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees.  Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Eli Lilly & Co. terlibat dalam penemuan, pengembangan, pembuatan, dan penjualan produk farmasi. Perusahaan ini berkantor pusat di Indianapolis, Indiana dan saat ini mempekerjakan 47.000 karyawan penuh waktu. Produk kesehatan kardiometaboliknya meliputi Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, dan lainnya; Humulin, Humulin 70/30, dan lainnya; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, dan VERVE-301. Produk onkologi-nya termasuk Cyramza, Erbitux, Tyvyt, dan Verzenio. Produk imunologinya meliputi Ebglyss, Olumiant, Omvoh, dan Taltz. Produk neuro ilmiah-nya termasuk Emgality dan Kisunla. Perusahaan ini, melalui anak perusahaannya, POINT Biopharma Global Inc., terlibat dalam penemuan, pengembangan, dan upaya pembuatan radiopharmaceutical, serta terapi radioligand klinis dan pra-klinis yang sedang dikembangkan untuk pengobatan kanker. Perusahaan ini juga sedang mengembangkan penghambat molekul kecil oral a4b7 integrin untuk penyakit radang usus (IBD).

Eli Lilly

NVIDIA

Apple

Microsoft

Google

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

JPMorgan

Walmart

Oracle

Visa

MasterCard

Exxon Mobil

Palantir

Netflix

Johnson & Johnson

SPDR S&P500 ETF

ASML

Alibaba

Costco

Bank of America

AbbVie

Home Depot

Procter & Gamble

General Electric

Chevron

UnitedHealth Group

Vanguard Total Stock Market ETF

Coca-Cola

Cisco

Wells Fargo

Caterpillar

Toyota

Morgan Stanley

AstraZeneca

Micron Technology

American Express

Salesforce

Goldman Sachs

Raytheon Technologies

Novartis

T-Mobile

Shopify

Philip Morris

Shell

Novo Nordisk

Abbott

Merck

McDonald's

Royal Bank of Canada

Disney

Invesco QQQ Trust

Uber

PepsiCo

Arista Networks

Lam Research

Linde PLC

QUALCOMM

ServiceNow

Intel

Intuitive Surgical

Intuit

Applied Materials

Citigroup

Blackstone

AT&T

Charles Schwab

NextEra Energy

BlackRock

Sony

Verizon

Booking Holdings

Amgen

Accenture

Boeing

Danaher

Banco Santander

Boston Scientific

Palo Alto Networks

Unilever

Gilead Sciences

S&P Global

Texas Instruments

Adobe

Toronto-Dominion Bank

Pfizer

Capital One

CrowdStrike

Spotify

TotalEnergies

Saham Eli Lilly

Tentang Eli Lilly

Statistik Kunci